TrmFO, a Fibronectin-Binding Adhesin of Mycoplasma bovis

Yongpeng Guo1, Hongmei Zhu2, Jiayao Wang3

  • 1College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China. gyp18771951786@gmail.com.

Insights

Methylenetetrahydrofolate-tRNA-(uracil-5-)-methyltransferase (TrmFO) from Mycoplasma bovis binds fibronectin, aiding bacterial adhesion to host cells. Antibodies against TrmFO show mycoplasmacidal activity, suggesting TrmFO as a potential therapeutic target.

Area of Science:

  • Veterinary Microbiology
  • Molecular Biology
  • Bacterial Pathogenesis

Background:

  • Mycoplasma bovis causes significant economic losses in the cattle industry.
  • Bacterial adhesion is critical for infection and colonization.
  • Fibronectin acts as a bridge between bacterial adhesins and host cell receptors.

Purpose of the Study:

  • To characterize the fibronectin-binding ability of methylenetetrahydrofolate-tRNA-(uracil-5-)-methyltransferase (TrmFO) from M. bovis.
  • To investigate the role of TrmFO in M. bovis cytoadherence to host cells.

Main Methods:

  • Cloning and expression of the trmFO gene in E. coli.
  • Generation of polyclonal antibodies against recombinant TrmFO (rTrmFO).
  • Ligand dot blot, ELISA, immunoblotting, mycoplasmacidal assays, and confocal laser scanning microscopy.

Main Results:

  • TrmFO was identified as an immunogenic component conserved across M. bovis isolates.
  • Recombinant TrmFO (rTrmFO) demonstrated dose-dependent binding to fibronectin.
  • rTrmFO and M. bovis adhesion to embryonic bovine lung cells were inhibited by anti-rTrmFO antibodies.
  • Anti-rTrmFO serum exhibited mycoplasmacidal activity in the presence of complement.

Conclusions:

  • TrmFO binds fibronectin and plays a role in M. bovis adhesion to host cells.
  • TrmFO is a potential virulence factor and a target for therapeutic intervention against M. bovis infections.